Marlon Garner

Marlon Garner serves as the primary procurement lead for the National Institutes of Health Office of the Director (NIH-OD), overseeing the strategic acquisition of specialized software solutions that underpin biomedical research infrastructure. In this role, he ensures the agency’s digital ecosystem supports secure, scalable, and interoperable platforms for clinical trial management, data analytics, and researcher access to high-performance computing environments. His procurement activities center on software publishing and development services critical to advancing scientific innovation, aligning closely with NIH-OD’s mission to modernize research operations through cutting-edge technology. He manages full lifecycle contracting processes—from requirements definition to contract award and performance oversight—for mission-critical software systems used across NIH laboratories and clinical research networks. Garner collaborates with a broad spectrum of software publishers and technology vendors, primarily engaging firms with proven expertise in biomedical data platforms, cloud-based research tools, and secure software deployment architectures. While no single contractor dominates his portfolio, he consistently works with vendors capable of delivering compliant, audit-ready solutions that meet federal cybersecurity and data governance standards. His working relationships are characterized by technical rigor, performance-based evaluation, and a preference for vendors with deep domain knowledge in life sciences software. Garner’s contracting activity is entirely non-set-aside, reflecting a focus on technical capability over socioeconomic categorization. His procurement strategy prioritizes solution quality, scalability, and compliance over demographic preferences, resulting in 100% of awards issued under open competition. This approach ensures NIH-OD secures the most capable and robust software systems available in the marketplace. His primary procurement focus is NAICS 513210—Software Publishers—reflecting an exclusive emphasis on commercial off-the-shelf and custom-developed software for scientific research. He procures enterprise-grade applications for genomic analysis, electronic data capture, laboratory information management, and secure research collaboration platforms, demonstrating deep expertise in the technical demands of biomedical software environments.